Allianz Asset Management
SCMP

Allianz Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Allianz Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-327,189
Closed -$3.59M – 2711
2016
Q2 		$3.59M Sell
327,189
-2,179
-0.7% -$24.4K ﹤0.01% 1657
2016
Q1 		$3.6M Buy
329,368
+10,525
+3% +$133K ﹤0.01% 1571
2015
Q4 		$5.57M Buy
318,843
+303,978
+2,045% +$5.45M 0.01% 1312
2015
Q3 		$295K Buy
14,865
+145
+1% +$3.32K ﹤0.01% 2197
2015
Q2 		$242K Sell
14,720
-41,950
-74% -$727K ﹤0.01% 2281
2015
Q1 		$882K Buy
56,670
+18,280
+48% +$283K ﹤0.01% 1824
2014
Q4 		$548K Buy
+38,390
New +$405K ﹤0.01% 1989

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Allianz Asset Management's SCMP Position: Q3 2016 in Review

Allianz Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 327,189 shares — an estimated $3.59M sold.

Allianz Asset Management first reported a position in SCMP in Q4 2014 and held it in 7 quarters. The position peaked at $5.57M in Q4 2015. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Allianz Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Allianz Asset Management sold 327,189 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $3.59M.
  • Allianz Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
  • Allianz Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $5.57M in Q4 2015.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Allianz Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.